FSEV 2026

Patio 44-45 - Ground floorConference registration

Auditorium - Level -1Welcome address

• Mehdi KABANI (CNRS, Le Kremlin-Bicêtre) & Christian NERI (INSERM, Paris)

SESSION 1: EVs & Cell Biology (I)

Joint session with the French Society of Cell Biology (SBCF)

Chairs: Dr Mehdi KABANI (CNRS, Le Kremlin-Bicêtre) & Dr Christian NERI (INSERM, Paris)

• Dr Vincent HYENNE (INSERM, Strasbourg)
  The formation of tumor EVs and their role in the development of pre-metastatic niches

Short talks

• S1.1 - Maribel LARA CORONA (Inserm, INEM, Paris)
  Shear stress induces extracellular vesicle secretion to promote plasma membrane repair in kidney tubular cells

• S1.2 - Laura SALAVESSA (INSERM, INEM, Paris)
  Melanin-associated EVs as a molecular passport regulating skin pigmentation

• S1.3 - Panagiotis PAPOUTSOGLOU (Institut Curie, Paris)
  Coupling cancer EV-mediated RNA invasion to epigenetic reprograming and cell plasticity at single cell level in monocytes

Flash talks 1

Chairs: Marylou PICHONNIÈRE (Université de Tours) & YN-FSEV

• FT-1.1 - Jana DHAYBI (BIPAR, ANSES, INRAE, Maison Alfort)
  Analysis of immunomodulatory potential of extracellular vesicles derived from Trichinella spp.

• FT-1.2 - Dalya GULSEREN (Neuro-Bicêtre, INSERM, CNRS, Le Kremlin-Bicêtre)
  Single molecule detection of Tau seeds in extracellular vesicles from Alzheimer’s disease brains

• FT-1.3 - Clara JOLLET (BRIC, INSERM, Bordeaux)
  Mutated β-catenin alters the immune response and chemokine network in hepatocellular carcinoma and uncovers CXCL16 as a novel extracellular vesicle cargo

Sponsor session 1

Chair: Mehdi KABANI (CNRS, Le Kremlin-Bicêtre)

• Particle Metrix
  ZetaView: The importance of fluorescence for EVs characterization using NTA technology
  Bertrand DAMART (Particle Metrix Gmbh)

• Secretech
  Discover hidden biology with single EV proteomics
  Yanling CAI (Secretech Biosciences)

• Takara Bio Europe
  Enabling Scalable, IND-Ready Manufacturing of MSC-Derived Extracellular Vesicles
  Karthi RAJAMANI (Takara Bio Europe)

Patio 44-45 - Ground floor & Level -1Lunch

Patio 44-45 - Ground floor & Level -1POSTER SESSION 1 - odd-numbered

Auditorium - Level -1SESSION 2: EVs & Technology (I)

Joint session with the Belgium and Luxembourg Society for Extracellular Vesicles for EVs (BELSEV)

Chairs: Pr An HENDRIX (Ghent University, Belgium) & Dr Lorena MARTIN JAULAR (Institut Curie, Paris)

• Pr An HENDRIX (Ghent University, Belgium)
  EVOKE, the first guiding tool for the informed selection of EV preparation methods

Short talks

• S2.1 - Camille MENACEUR VANDENBROUCKE (Aarhus University, Denmark)
  Tracing the Protein Corona Footprint of Extracellular Vesicles Mapped In Situ by EV-SPEC in Cells and Zebrafish

• S2.2 - Jessica SCHIAVI-TRITZ (Université de Lorraine, Vandoeuvre-les-Nancy)
  Modulation of the cell culture microenvironment to fine-tune the production and functionality of extracellular vesicles

• S2.3 - Ahmad MASWADEH (Institut Curie, Paris)
  A novel, label-free, unbiased proteomic profiling resolves changes of EV subtypes upon drug treatment of cancer cells

Patio 44-45 - Ground floor & Level -1Coffee break

Patio 44-45 - Ground floor & Level -1POSTER SESSION 1 - odd-numbered

Auditorium - Level -1SESSION 3: EVs & Cancer

Chairs: Dr Gisela D’ANGELO (Institut Curie, Paris) & Dr Jessica GOBBO (CGFL, INSERM 1231, Dijon)

• Dr Annalisa RADEGHIERI (University of Brescia, Italy)
  The dynamic identity of extracellular vesicles in cancer therapy

Short talks

• S3.1 - Isen NAIKEN (Université de Bourgogne Europe, Dijon)
  First-in-human study of extracellular vesicle biomarkers to forecast treatment response in Hodgkin lymphoma

• S3.2 - Julio BUNAY (CRCT, Toulouse)
  Cholesterol Metabolites as Regulators of Tumor Exosome Immunity

• S3.3 - Laetitia GUEVEL (CRCI2NA, Nantes)
  Longitudinal profiling of circulating extracellular vesicles as biomarkers of response to neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer

• S3.4 - Sebastien JAULIAC (INSERM, Paris)
  A combinatorial EV-associated miRNA signature recapitulates the anti-tumoral activity of NFAT3-regulated extracellular vesicles in aggressive cancers

Day 1 closing - Information for day 2

Invited speakers dinner